newsInvesting $700mn to establish a new site, Eli Lilly plans…
23 February 2022 | By Hannah Balfour (European Pharmaceutical Review)
Investing $700mn to establish a new site, Eli Lilly plans to fuel the development of genetic medicines through the company’s new Institute for Genetic Medicine.